Treatment quality for heart failure should be measured on guideline adherence, not patient volume

A new study has found that adherence to treatment guidelines, not patient volume, is a better method of predicting treatment outcomes for patients with heart failure. The study was recently published in the journal Circulation.

Credit: Dmitry Kalinovsky/Shutterstock.com

Heart failure is a condition that causes a reduction in the heart's ability to pump blood. Normally, the heart pumps blood to supply vital nutrients and oxygen to all parts of the body.

In heart failure, the heart has difficulty pumping adequately and starts to function in an abnormal manner to compensate. This is a chronic condition that needs to be managed with medications.

The American Heart Association's 2017 Heart Disease and Stroke Statistical Update reported that 6.5 million Americans suffer from heart failure, and numbers look only set to rise.

The current study was led by Dr Dharam Kumbhani, M.D. S.M, assistant professor of medicine and a cardiologist at UT Southwestern Medical Center in Dallas.

There is a feeling that hospitals that perform more procedures or treat more patients for a certain condition are likely to have better outcomes. But what we have found in this study, and others we have conducted, is that patients at hospitals with established processes of care fare better.”

Dr Dharam Kumbhani, M.D. S.M, Lead Author and Assistant Professor of Medicine at UT Southwestern Medical Center, Dallas.

The team looked at the medical records of 125,595 patients who were over the age of 65. All patients had developed heart failure and subsequently underwent treatment at 342 hospitals.

These hospitals were all a part of the “Get With The Guidelines” initiative by the American Heart Association, which took place between 2005 to 2014. The number of patients admitted with heart failure each year ranged between 5 and 147 in each of the hospitals.

The results showed that the hospitals who admitted more patients also adhered to the process measures for heart failure as prescribed by the AHA. This included testing, administering appropriate drugs and counseling for smoking cessation.

These hospitals also prescribed more number of cardiac resynchronization therapy devices and implantable cardioverter defibrillators upon discharge.

In hospitals that adhered to the guidelines, there was no difference in readmissions or death rates both during the patients’ stay in hospital and within 30 days of discharge.

Compared to hospitals that did not adhere to the guidelines, deaths and readmissions within 6 months of discharge were lower.

Going to a high-volume medical center for heart failure doesn't guarantee that you'll have the best outcomes. Identifying the hospitals that provide the best care is more complicated than that, and patients and health policy makers should recognize that smaller-volume hospitals can deliver outstanding care."

Dr Dharam Kumbhani, M.D. S.M, Lead Author and Assistant Professor of Medicine at UT Southwestern Medical Center, Dallas.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, June 20). Treatment quality for heart failure should be measured on guideline adherence, not patient volume. News-Medical. Retrieved on November 16, 2024 from https://www.news-medical.net/news/20180130/Treatment-quality-for-heart-failure-should-be-measured-on-guideline-adherence-not-patient-volume.aspx.

  • MLA

    Mandal, Ananya. "Treatment quality for heart failure should be measured on guideline adherence, not patient volume". News-Medical. 16 November 2024. <https://www.news-medical.net/news/20180130/Treatment-quality-for-heart-failure-should-be-measured-on-guideline-adherence-not-patient-volume.aspx>.

  • Chicago

    Mandal, Ananya. "Treatment quality for heart failure should be measured on guideline adherence, not patient volume". News-Medical. https://www.news-medical.net/news/20180130/Treatment-quality-for-heart-failure-should-be-measured-on-guideline-adherence-not-patient-volume.aspx. (accessed November 16, 2024).

  • Harvard

    Mandal, Ananya. 2019. Treatment quality for heart failure should be measured on guideline adherence, not patient volume. News-Medical, viewed 16 November 2024, https://www.news-medical.net/news/20180130/Treatment-quality-for-heart-failure-should-be-measured-on-guideline-adherence-not-patient-volume.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Comparing camel, cow, and goat milk: Which is best for diabetes and heart health?